CEO Serge Saxonov highlighted strong growth ... Macroeconomic uncertainties could impact spending in academia and biopharma. 10x Genomics delivered strong Q4 2023 results with substantial ...

Genomics , a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the ...

Sand Hill Road Host Scott McGrew spoke with Jim Tananbaum to learn more about how artificial intelligence is fueling ...

10x Genomics disclaims any intention or obligation ... Joining the call today are Serge Saxonov, our CEO and Co-Founder; and Adam Taich, our Chief Financial Officer. We will host a question ...

10x Genomics, Inc. (NASDAQ ... Joining the call today are Serge Saxonov, our CEO and Co-Founder; and Adam Taich, our Chief Financial Officer. We will host a question-and-answer session after ...

Zimmer Biomet appoints Kristen Cardillo as SVP and Chief Communications Officer to lead global strategy and stakeholder engagement.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of ...

This collaboration will use 10x Genomics’ Chromium GEM-X technology ... PhD, founder and CEO of Ultima Genomics. “Initiatives like the Billion Cells Project showcase advances enabled by ...

A growing leader in the diagnostics space, Nucleus Genomics expands access to genetic screening and testing beyond what patients may be able to get from their regular healthcare providers. The company ...

Reporting to President and CEO Ivan Tornos, Ms. Cardillo will join ... Ms. Cardillo joins Zimmer Biomet from life science tools company 10x Genomics, where she was Vice President of Corporate ...